课题基金 / 基金详情

MITOGEN MEDIATED SIGNAL TRANSDUCTION IN CARCINOGENESIS

MITOGEN MEDIATED SIGNAL TRANSDUCTION IN CARCINOGENESIS
致癌过程中丝裂原介导的信号转导
批准号:
3752738
负责人:
S S THORGEIRSSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

S S THORGEIRSSON的其他基金

相似基金

相关文献

中文摘要
翻译
利用基因工程嵌合分子在表皮生长 因子受体(EGFR)和gp 185-erbB-2,这项研究进行, 研究和表征不同的分子基础 EGFR和erbB-2激酶的生物学特性。 NIH 3 T3细胞, 过表达EGFR(NIH-EGFR)或嵌合EGFR/erbB-2受体(NIH-erbB-2受体)的小鼠, EGFR/erbB-2)的细胞外配体结合结构域 和gp 185-erbB-2的胞内转导活性域, 在37 ℃下用50 nM EGF触发15分钟。 磷酸酪氨酸 用抗-pTyr抗体免疫沉淀(pTyr)蛋白, 使用二维聚丙烯酰胺凝胶电泳(2D- PAGE)和抗pTyr免疫印迹分析。 几种蛋白质被 EGFR或erbB-2特异性磷酸化, 不同的化学计量 在NIH 3 T3细胞中,erbB-2比正常细胞高100倍。 比EGFR转化。 与这种转变能力相伴随的是 erbB-2对至少28种蛋白质的优先磷酸化, 与EGFR相比。 确定哪些基质可能直接 参与有丝分裂信号传导,磷酸化蛋白质的2D-PAGE图谱 EGFR/erbB-2-TK是一种嵌合分子, erbB-2激酶(TK)结构域取代了EGFR,EGFR/ret, 含有ret激酶(一种TK)细胞内部分的嵌合体 属于不同的受体酪氨酸激酶(RTK)家族, 利用。 EGFR/erbB-2-TK和EGFR/ret均表现出erbB-2样表达。 生物学表型,高效转化NIH 3 T3。 这是 预计使用这种嵌合体可以帮助识别 erbB-2介导的促有丝分裂信号的特异性底物。 在所有 pTyr蛋白表达、桩蛋白和23 kDa底物的模式是 总是磷酸化到更高的化学计量, 有丝分裂和转化信号被激活。 拟将 桩蛋白和23 kDa底物是erbB-2中的重要元件 和RET激活的促有丝分裂信号传导。
英文摘要
Using genetically engineered chimeric molecules between epidermal growth factor receptor (EGFR) and gp185-erbB-2, this study was undertaken to investigate and characterize the molecular basis of the different biological properties of EGFR and erbB-2 kinases. NIH3T3 cells, overexpressing (NIH-EGFR) or the chimeric EGFR/erbB-2 receptor (NIH- EGFR/erbB-2) containing the extracellular ligand-binding domain of EGFR and the intracellular transduction competent-domain of gp185-erbB-2, were triggered with 50 nM EGF for 15 minutes at 37 degrees C. Phosphotyrosine (pTyr) proteins were immunoprecipitated with anti-pTyr antibodies and analyzed using two-dimensional polyacrylamide gel electrophoresis (2D- PAGE) and anti-pTyr immunoblot analysis. Several proteins were specifically phosphorylated by either EGFR or erbB-2 with markedly different stoichiometry. In NIH3T3 cells, erbB-2 is 100-fold more transforming than EGFR. Concomitant with this transforming capacity is the preferential phosphorylation of at least 28 proteins by erbB-2, as compared to EGFR. To identify which substrates might be directly involved in mitogenic signaling, 2D-PAGE maps of proteins phosphorylated on tyrosine by EGFR/erbB-2-TK, a chimeric molecule in which the tyrosine kinase (TK) domain of erbB-2 replaced that of EGFR, and EGFR/ret, a chimera containing the intracellular portion of ret kinase, a TK belonging to a different family of receptor tyrosine kinases (RTKs), were utilized. Both EGFR/erbB-2-TK and EGFR/ret display an erbB-2-like biological phenotype and transform NIH3T3 with high efficiency. It was anticipated that the use of such chimeras could aid in the identification of specific substrates for erbB-2 mediated mitogenic signaling. In all patterns of pTyr protein expression, paxillin and a 23 kDa substrate were invariably phosphorylated to higher stoichiometry whenever potent mitogenic and transforming signals were activated. It is proposed that paxillin and the 23 kDa substrate are important elements in the erbB-2 and ret-activated mitogenic signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLONING OF THE RAT MDR GENE FAMILY AND REGULATION IN NORMAL AND NEOPLASTIC LIVER
HEPATIC STEM CELL COMPARTMENT AND LIVER TUMORS
ANALYSIS OF GENETIC ALTERATIONS DURING HEPATOCARCINOGENESIS
ANALYSIS OF CELLULAR AND GENETIC ALTERATIONS DURING HEPATOCARCINOGENESIS
海外基金